Coronary Artery Disease

ACC 2025: Lifetime Benefit by Control of Modifiable Risk Factors

Christina Magnussen

Watch time: 2m 46s

Luai Madanat , Ahmad Jabri , Michael Gallagher , et al

Read time: 8m 6s

Adhya Mehta , Roger S Blumenthal , Ty J Gluckman , et al

Read time: 19m 16s

Victoria Delgado, Laura Sanchis, Julia Grapsa et al

Nicholas Nguyen , Katherine C Michelis

Read time: 20m 28s
AHA 24: The ALPACAR Trial

Steven E Nissen

Watch time: 5m 28s
AHA 24: The BROOKLYN Study

Stephen Nicholls

Watch time: 3m 44s
AHA 24: The KRAKEN Trial

Stephen Nicholls

Watch time: 3m 40s
AHA 24: New Insights from CLEAR OUTCOMES

Marc P Bonaca

Watch time: 3m 49s
AHA 24 Late-Breaking Discussion: The ZODIAC Trial

Harriette Van Spall, Kausik Ray

Watch time: 29m 32s
AHA 24 Late-Breaking Discussion: The NUDGE-FLU Study

Harriette Van Spall, Tor Biering-Sørensen

Watch time: 18m 41s
AHA 24: The LIBerate-OLE Trial

Dean J Kereiakes

Watch time: 6m 17s

Heather Currie , Christine Williams

Read time: 10m

Edward T Carreras , Donna M Polk

FOURIER-OLE: Implications for Real-World Practice

Robert P Giugliano

Watch time: 2m 56s
FOURIER-OLE: Long-term Safety of Evolocumab Therapy in Patients with Evident ASCVD

Michelle O'Donoghue

Watch time: 3m 30s

Sergio Fazio

Charles H Hennekens , Danielle Hollar , Arthur S Agatston

Marc Sirol

Victoria Delgado, Laura Sanchis, Julia Grapsa et al

Yassir Javaid et al

Watch time: 18m 47s (4 videos)

Abdulah Alrifai , Mohamad Kabach , Jonathan Nieves , et al

Marsha M Neumyer , Bill Bertolino

Read time: 11m

Yugo Yamashita

Media

AHA 23: Preventive Cardiology in 2023

Michael Honigberg

Watch time: 7m 3s

Nicolas M Van Mieghem, Joost Daemen

Watch time: 1h 35m 42s (16 videos)
ESC 23 Late-Breaker Discussion: The RECORD MI Registry

Harriette Van Spall, Javed Butler

Watch time: 9m 37s
ESC 23: The ILUMIEN IV Trial

Ziad A Ali

Watch time: 4m 12s

Yugo Yamashita

Joost Daemen, Allen Jeremias, Ziad A Ali et al

Watch time: 55m 46s (1 video)
ACC 23: Effect of Evolocumab on Coronary Plaque Morphology: The YELLOW III Study

Annapoorna Kini

Watch time: 8m 1s
ACC.23 Late-Breaker Discussion: The CLEAR-Outcomes Trial

Harriette Van Spall, Steven E Nissen

Watch time: 16m 12s
View from the Thoraxcenter: What's Hot at ACC.23?

Nicolas M Van Mieghem, Joost Daemen

Watch time: 22m 4s
Radcliffe & CardioNerds @AHA22: Reduction of Lp(a) With Small Interfering RNA

Gurleen Kaur, Michelle O'Donoghue

Watch time: 14m 28s
Radcliffe & CardioNerds @AHA22: Reduction of Triglycerides With Pemafibrate

Aruna D Pradhan, Gurleen Kaur

Watch time: 14m 20s
FOURIER-OLE: Implications for Real-World Practice

Robert P Giugliano

Watch time: 2m 56s

Media

ACC 2025: Lifetime Benefit by Control of Modifiable Risk Factors

Christina Magnussen

Watch time: 2m 46s
ESC 23: LIBerate-HeFH Study

Frederick Raal

Watch time: 4m 16s
View from the Thoraxcenter: ACC.23 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen

Watch time: 33m 36s
ESC 23 Late-Breaker Discussion: The RECORD MI Registry

Harriette Van Spall, Javed Butler

Watch time: 9m 37s

Nicolas M Van Mieghem, Joost Daemen

Watch time: 1h 35m 42s (16 videos)

Yugo Yamashita

ESC 24: Day 4 Wrap-Up with Dr Alasnag and Dr Al-Shaibi

Mirvat Alasnag, Khaled Al-Shaibi

Watch time: 15m 45s
AHA 24: New Insights from CLEAR OUTCOMES

Marc P Bonaca

Watch time: 3m 49s
AHA 24: The ALPACAR Trial

Steven E Nissen

Watch time: 5m 28s
AHA 24: The BROOKLYN Study

Stephen Nicholls

Watch time: 3m 44s
AHA 24: The KRAKEN Trial

Stephen Nicholls

Watch time: 3m 40s
AHA 24: The LIBerate-HeFH_OLE Study

Frederick Raal

Watch time: 3m 53s

Articles

Anomalous Coronary Artery Origin

Luai Madanat

,

Ahmad Jabri

,

Michael Gallagher

,

Elvis Cami

,

Richard Bloomingdale

,

Published:

01 April 2025

Citation:

US Cardiology Review 2025;19:e09.

DOI:

https://doi.org/10.15420/usc.2024.57
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 372
  • Downloads: Downloads 20
  • Read time: 8m 6s

HsCRP in ASCVD

Adhya Mehta

,

Roger S Blumenthal

,

Ty J Gluckman

,

David I Feldman

,

Payal Kohli

,

Published:

21 March 2025

Citation:

US Cardiology Review 2025;19:e06.

DOI:

https://doi.org/10.15420/usc.2024.25
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 730
  • Downloads: Downloads 63
  • Read time: 19m 16s

Lifestyle Modification after PCI

Nicholas Nguyen

,

Katherine C Michelis

,

Published:

09 January 2025

Citation:

US Cardiology Review 2025;19:e01.

DOI:

https://doi.org/10.15420/usc.2024.34
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 1200
  • Downloads: Downloads 83
  • Read time: 20m 28s

MI and Non-obstructive Coronary Arteries

Yetunde A Fatade

,

Noah A Newman

,

Nidhi H Patel

,

Puja K Mehta

,

Published:

23 July 2024

Citation:

US Cardiology Review 2024;18:e10.

DOI:

https://doi.org/10.15420/usc.2023.12
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 3170
  • Downloads: Downloads 226
  • Citations: 1
  • Read time: 15m 57s